Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

8 Results

Guidelines and Advice

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Status: Archived
ID: CED 16

Jan 2010

Guidelines and Advice

Zoledronic Acid for Metastatic Renal Cell Carcinoma (MRCC)

Status: Archived
ID: CED 18

Jun 2010

Guidelines and Advice

The Role of the Taxanes in the Management of Metastatic Breast Cancer

Status: Archived
ID: 1-3 Version 2.2003
Version: 2.2003

Jun 2010

Guidelines and Advice

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

Status: Archived
ID: 1-9

Jun 2010

Guidelines and Advice

Thalidomide in Multiple Myeloma

Status: Archived
ID: 6-21

Jan 2010

Guidelines and Advice

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Status: In-Review
ID: 2-4
Version: 3

Mar 2019

Guidelines and Advice

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Status: Current
ID: N/A
Version: N/A

Mar 2019

Guidelines and Advice

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Status: Current

Mar 2019